Cymbalta (duloxetine hydrochloride) is an antidepressant in the serotonin-norepinephrine reuptake inhibitor (SNRI) category.
However, there isn't much research on the effects between Cymbalta and pregnancy. Cymbalta is labeled by the FDA as a Category C risk category
Cymbalta TE Rating: AB Therapeutic Category: Antidepressant. Download Safety Data Sheet Package Insert Medication Guide. Category: Generics. Related
Cymbalta (duloxetine hydrochloride) is an antidepressant in the serotonin-norepinephrine reuptake inhibitor (SNRI) category.
However, there isn't much research on the effects between Cymbalta and pregnancy. Cymbalta is labeled by the FDA as a Category C risk category
Cymbalta (duloxetine hydrochloride) is an antidepressant in the serotonin-norepinephrine reuptake inhibitor (SNRI) category.
Cymbalta (duloxetine hydrochloride) is an antidepressant in the serotonin-norepinephrine reuptake inhibitor (SNRI) category.
FDA pregnancy category C. It is not known whether Cymbalta will harm an unborn baby. However. Cymbalta may cause problems in a newborn if
Cymbalta is labeled by the FDA as a Category C risk category medication, meaning that there haven't been enough high-quality studies in humans
Comments